Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system
- PMID: 10531282
- PMCID: PMC97008
- DOI: 10.1128/IAI.67.11.6164-6167.1999
Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system
Abstract
With a coincubation model incorporating Pseudomonas aeruginosa and human polymorphonuclear neutrophils (PMNs), a cystic fibrosis (CF) P. aeruginosa isolate has been shown to resist the bactericidal action of PMNs and to induce their cellular death. An isogenic mutant of this CF isolate in which the type III secretion system was rendered nonfunctional was unable to induce cellular death of PMNs.
Figures



Similar articles
-
Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.Infect Immun. 2000 May;68(5):2916-24. doi: 10.1128/IAI.68.5.2916-2924.2000. Infect Immun. 2000. PMID: 10768989 Free PMC article.
-
Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.Infect Immun. 2014 Nov;82(11):4477-86. doi: 10.1128/IAI.01969-14. Epub 2014 Aug 11. Infect Immun. 2014. PMID: 25114118 Free PMC article.
-
Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.J Cyst Fibros. 2011 Jul;10(4):265-71. doi: 10.1016/j.jcf.2011.03.004. Epub 2011 Apr 3. J Cyst Fibros. 2011. PMID: 21463973
-
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.Front Cell Infect Microbiol. 2017 Jun 30;7:243. doi: 10.3389/fcimb.2017.00243. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28713772 Free PMC article. Review.
-
Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.Surv Synth Pathol Res. 1985;4(1):14-33. doi: 10.1159/000156962. Surv Synth Pathol Res. 1985. PMID: 3927464 Review. No abstract available.
Cited by
-
Calcium chelation by alginate activates the type III secretion system in mucoid Pseudomonas aeruginosa biofilms.PLoS One. 2012;7(10):e46826. doi: 10.1371/journal.pone.0046826. Epub 2012 Oct 8. PLoS One. 2012. PMID: 23056471 Free PMC article.
-
Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention.PLoS One. 2011 Feb 15;6(2):e16963. doi: 10.1371/journal.pone.0016963. PLoS One. 2011. PMID: 21347240 Free PMC article.
-
Early Cytokine Induction Upon Pseudomonas aeruginosa Infection in Murine Precision Cut Lung Slices Depends on Sensing of Bacterial Viability.Front Immunol. 2020 Oct 30;11:598636. doi: 10.3389/fimmu.2020.598636. eCollection 2020. Front Immunol. 2020. PMID: 33250899 Free PMC article.
-
Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.BMC Microbiol. 2016 Jul 8;16(1):137. doi: 10.1186/s12866-016-0756-x. BMC Microbiol. 2016. PMID: 27392067 Free PMC article.
-
Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.BMC Bioinformatics. 2006 May 30;7:272. doi: 10.1186/1471-2105-7-272. BMC Bioinformatics. 2006. PMID: 16734902 Free PMC article.
References
-
- Attree, I. Unpublished data.
-
- Coburn J, Wyatt R T, Iglewski B H, Gill D M. Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S. J Biol Chem. 1989;264:9004–9008. - PubMed
-
- Delic-Attree I, Toussaint B, Froger A, Willison J C, Vignais P M. Isolation of an IHF-deficient mutant of a Pseudomonas aeruginosa mucoid isolate and evaluation of the role of IHF in algD gene expression. Microbiology. 1996;142:2785–2793. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical